Shanghai Cancer Center

The trials here

What the 22 trials at this site are about, from their registry records.

Conditions

• Pancreatic cancer11 trials
• Childhood cancers3 trials
• Lung cancer3 trials
• Colorectal cancer2 trials
• Brain metastases1 trial
• Cervical cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Mantle cell lymphoma1 trial
• Prostate cancer1 trial

Phase

• Phase 27 trials
• Phase 35 trials
• Phase 2/33 trials

Status

• Recruiting14 trials
• Active, not recruiting3 trials
• Completed3 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial

Lead sponsor

• Fudan University17 trials
• ADC Therapeutics S.A.1 trial
• BioNTech SE1 trial
• Canadian Cancer Trials Group1 trial
• Hutchmed1 trial
• and 1 more

Running trials

• Enrolling by invitation

  Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

  NCT07441369· Phase 2· Fudan University· Source

• Recruiting

  A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

  NCT07365995· Phase 3· BioNTech SE· Source

• Not yet recruiting

  Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes

  NCT07272109· Phase 3· Fudan University· Source

  Contact: Guopei Luo

• Recruiting

  Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas

  NCT07183280· Fudan University· Source

  Contact: Guopei Luo

• Recruiting

  Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

  NCT06914674· Phase 2· Fudan University· Source

  Contact: Xia Huanyu MD

• Active, not recruiting

  Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol

  NCT06754293· Fudan University· Source

• Recruiting

  Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

  NCT06598033· Phase 2/3· Fudan University· Source

  Contact: Yi Li, MD

• Recruiting

  Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer

  NCT06601283· Phase 2/3· Fudan University· Source

  Contact: Yi Liu, MD

• Recruiting

  AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases

  NCT06604689· Fudan University· Source

  Contact: Zhengfei Zhu, PhD

• Recruiting

  A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

  NCT06341556· Phase 2· Fudan University· Source

  Contact: Yizhen Liu

• Recruiting

  Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

  NCT06250972· Phase 3· Fudan University· Source

  Contact: Ying Yang, MD

• Recruiting

  mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy

  NCT06249321· Phase 2· Fudan University· Source

  Contact: Ying Yang, MD

• Recruiting

  Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer

  NCT06196788· Phase 2· Fudan University· Source

  Contact: Guopei Luo, MD

• Recruiting

  mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

  NCT06149689· Phase 2· Fudan University· Source

  Contact: Ying Yang, MD

• Recruiting

  Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

  NCT06095141· Phase 2/3· Fudan University· Source

  Contact: Ying Yang, MD

• Recruiting

  Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

  NCT06017284· Phase 3· Fudan University· Source

  Contact: Ying Yang, MD

• Active, not recruiting

  PET-CT Predicting Lymph Nodes Metastasis

  NCT05970913· Fudan University· Source

• Recruiting

  Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

  NCT04527861· Ruijin Hospital· Source

  Contact: Ye Xu, MD

• Active, not recruiting

  Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04384484· Phase 3· ADC Therapeutics S.A.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pancreatic cancer11 recruiting
• Childhood cancers2 recruiting
• Colorectal cancer2 recruiting
• Brain metastases1 recruiting
• Lung cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  Tazemetostat for the Treatment of Relapsed/Refractory Follicular Lymphoma

  NCT05467943· Phase 2· Hutchmed· Source

• Completed

  Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

  NCT06613633· Fudan University· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Canadian Cancer Trials Group· Source